相关实验视频

Updated: Jun 21, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

突变IDH1抑制诱导dDNA传感激活瘤免疫力

Meng-Ju Wu^1,2,3,4, Hiroshi Kondo^1,2,3,4, Ashwin V Kammula^1,3,4

¹Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston MA, USA.

Science (New York, N.Y.)

|July 11, 2024

概括

突变异酸脱酶1 (mIDH1) 通过沉默CGAS传感器来抑制抗瘤免疫力. 抑制mIDH1可以恢复CGAS,从而激活抗癌免疫反应.

科学领域:

癌症学
免疫学
表观遗传学

背景情况:

异酸脱酶1 (IDH1) 突变在人类癌症中很常见.
突变的IDH1 (mIDH1) 产生R- 2基酸盐,影响表观酶.
在IDH1突变瘤中,通常会出现T细胞排斥,阻碍抗瘤免疫力.

研究的目的:

定义mIDH1驱动的免疫逃避的细胞自主机制.
研究mIDH1如何影响先天免疫信号通路.
探索mIDH1抑制对抗瘤免疫力的治疗潜力.

主要方法:

对IDH1突变固体瘤的分析.
调查CGAS传感器在免疫逃避中的作用.
评估mIDH1抑制对DNA甲基化和基因表达的影响.
研究可转移元素 (TE) 的dDNA对cGAS的激活.

主要成果:

IDH1突变瘤呈现高甲基化和CGAS传感器的沉默,从而损害了先天免疫力.
抑制mIDH1导致DNA脱甲基化和CGAS和TE的减压.
来自TE逆转录酶 (TE-RT) 的dsDNA激活cGAS,模仿病毒感染.
这种激活会触发抗瘤免疫反应.

结论:

通过沉默CGAS,mIDH1通过表观遗传抑制先天免疫力.
内源逆转录酶 (RT) 活性与FDA批准的瘤药物的作用机制有关.
通过抑制mIDH1恢复CGAS信号增强了抗瘤免疫力.

更多相关视频

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...